DDH Guideline Highlights

Terry Stanton

The clinical practice guideline (CPG) for “Management of Detection and Nonoperative Management of Pediatric Developmental Dysplasia of the Hip (DDH) in Infants Up to Six Months of Age” helps clarify the criteria for determining which patients should be screened and when (Table 1). The two most significant recommendations, each categorized as Moderate in strength in terms of supporting evidence, offer the following guidance:

CPGs characterize evidence as Strong, Moderate, Limited, or Consensus. Moderate evidence is that derived from two or more Moderate strength studies with consistent findings, or evidence from a single High quality study for recommending for or against the intervention. A Moderate recommendation means that the benefits exceed the potential harm (or that the potential harm clearly exceeds the benefits in the case of a negative recommendation), but the quality/applicability of the supporting evidence is not as strong.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!